In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004

Tekijä Hecht, David W., Galang, Minerva A., Sambol, Susan P., Osmolski, James R., Johnson, Stuart, Gerding, Dale N.
Julkaistu 2007

Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027

Tekijä Wieczorkiewicz, Jeffrey T., Lopansri, Bert K., Cheknis, Adam, Osmolski, James R., Hecht, David W., Gerding, Dale N., Johnson, Stuart
Julkaisussa Antimicrob Agents Chemother (2015)

Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients

Tekijä Kociolek, Larry K., Gerding, Dale N., Osmolski, James R., Patel, Sameer J., Snydman, David R., McDermott, Laura A., Hecht, David W.
Julkaisussa Antimicrob Agents Chemother (2016)

Kibdelomycin Is a Potent and Selective Agent against Toxigenic Clostridium difficile

Tekijä Miesel, Lynn, Hecht, David W., Osmolski, James R., Gerding, Dale, Flattery, Amy, Li, Fangbiao, Lan, Jing, Lipari, Philip, Polishook, Jon D., Liang, Lianzhu, Liu, Jenny, Olsen, David B., Singh, Sheo B.
Julkaistu 2014